NYXH News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

NY

Mkt Cap

$114.0M

Volume

207.68K

Next Earnings

November 12th

Loading chart

NY

NYXHNyxoah SA Ordinary Shares

NYXH

Pay with—

Available Balance0.00

NY

Mkt Cap

$113.0M

Volume

207.68K

Next Earnings

November 12th

Chart Financials Earnings News About Insider Filings

Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?Schrodinger shares surged 7.6% to close at $32.6, driven by investor optimism following the announcement of Tectora, a new biotech company co-founded by Schrodinger, NEA, and RA Capital Management focused on immunology and inflammation therapies. The company secured $55 million in Series A funding. Despite expected quarterly losses of $0.66 per share and a 15.3% revenue decline, consensus EPS estimates have been revised 72.2% higher over the past 30 days, suggesting potential for continued strength. SDGR carries a Zacks Rank #3 (Hold).Zacks Investment Research · Oct 6, 2026

Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE TrialNyxoah (NYXH) initiated its U.S. post-approval BREATHE study with the first patient implanted using the Genio system for obstructive sleep apnea treatment. The study will enroll up to 229 patients across 25 U.S. centers over five years to generate real-world evidence supporting physician adoption and payer reimbursement. Despite the milestone, NYXH shares fell approximately 8% following the announcement.Zacks Investment Research · Sep 8, 2026

Nyxoah Annonce l’Implantation du Premier Patient dans BREATHE, l’Étude Post-Approbation Américaine du Système Genio®Nyxoah announced the first patient implantation in BREATHE, a post-approval U.S. study of its Genio® system for obstructive sleep apnea treatment. The study will implant up to 229 patients across 25 U.S. centers over five years to evaluate long-term safety and efficacy in real-world clinical practice. The first procedure was performed by Dr. Rolando Molina at South Florida ENT Associates.GlobeNewswire Inc. · Sep 7, 2026

Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® SystemNyxoah announced the first patient implantation in BREATHE, a U.S. post-approval study of its Genio system for obstructive sleep apnea treatment. The multicenter study will implant up to 229 patients across 25 U.S. centers and follow them for up to five years to evaluate long-term safety and effectiveness of the bilateral hypoglossal nerve stimulation therapy in real-world clinical practice.GlobeNewswire Inc. · Sep 7, 2026

Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 9 juillet 2026Nyxoah has secured $15 million in non-dilutive debt funding from the European Investment Bank, complementing the company's June equity raise and bringing total capital raised to $110 million. The company is also holding an extraordinary general shareholders' meeting on July 9, 2026, to renew authorization for capital increases.GlobeNewswire Inc. · Jun 19, 2026

Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) has announced an extraordinary shareholders' meeting scheduled for July 9, 2026, to vote on renewing the board of directors' authorization to increase the company's share capital. The meeting will allow shareholders to participate in-person or via video conference, with voting available through proxy or mail.GlobeNewswire Inc. · Jun 19, 2026

Informations sur le nombre total de droits de vote et d'actionsNyxoah SA completed an underwritten public offering of 55.2 million new shares to accelerate the U.S. commercial launch of its Genio product, raising $110 million in aggregate financing. The offering included both public shares in the U.S. and private placements to qualified investors internationally, including the EU.GlobeNewswire Inc. · Jun 10, 2026

Information on the total number of voting rights and sharesNyxoah SA completed an underwritten public offering, issuing 55,232,558 new shares to accelerate the U.S. commercial launch of its Genio product. The company secured $110 million in aggregate financings. Following the offering, the total number of voting rights increased to 99,926,284 ordinary shares.GlobeNewswire Inc. · Jun 10, 2026

Publication relating to transparency notificationsNyxoah SA announced that it received a transparency notification on March 19, 2026, regarding Robert Taub and Robelga SRL crossing above the 3% threshold on December 30, 2025. The combined holding represents 10.14% of total voting rights (4,360,800 voting rights out of 43,026,460), consisting of 4,310,800 voting rights linked to securities and 50,000 equivalent financial instruments in the form of warrants.GlobeNewswire Inc. · Mar 20, 2026

Publication relative à des notifications de transparenceNyxoah SA announced that it received a transparency notification on March 19, 2026, regarding Robert Taub and his related entity Robelga SRL crossing the 3% voting rights threshold on December 30, 2025. Robert Taub and his controlled entities now hold 4,360,800 voting rights (10.14% of total voting rights), comprising 4,310,800 voting rights attached to securities and 50,000 assimilated financial instruments.GlobeNewswire Inc. · Mar 20, 2026

to start trading

NY

NYXHNyxoah SA Ordinary Shares

NYXH

Pay with—

Available Balance0.00

Your PositionYou don't own any NYXH yet.

Related Tickers

Earnings